D'ANGELO, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 137
NA - Nord America 60
AS - Asia 33
AF - Africa 2
Totale 232
Nazione #
IT - Italia 65
US - Stati Uniti d'America 60
IE - Irlanda 39
SG - Singapore 18
CN - Cina 14
SE - Svezia 10
FR - Francia 9
DE - Germania 6
AT - Austria 4
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IN - India 1
NL - Olanda 1
Totale 232
Città #
Dublin 37
Parma 21
Ashburn 12
Shanghai 10
Boardman 9
Singapore 9
Reggio Emilia 7
Chandler 6
Marseille 6
Munich 6
Macomer 4
Vienna 4
Milan 3
Strasbourg 3
Abidjan 2
Alba 2
Bologna 2
Chicago 2
Garden City 2
Montelupone 2
New York 2
Parkville 2
Piscataway 2
Seattle 2
Stockholm 2
Wuxi 2
Amsterdam 1
Baricella 1
Brno 1
Collecchio 1
Colmenar Viejo 1
Dallas 1
Des Moines 1
Fairfield 1
Helsinki 1
Neviano degli Arduini 1
Palermo 1
Princeton 1
Santa Clara 1
Sound Beach 1
Verona 1
Totale 176
Nome #
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 60
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 58
Respicell(TM): An innovative dissolution apparatus for inhaled products 51
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 41
Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device 20
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 16
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 3
Totale 249
Categoria #
all - tutte 1.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 6 0 0 0 0 0 1 4
2022/202368 2 3 1 4 1 2 11 9 20 8 4 3
2023/2024109 6 2 2 6 9 9 30 6 3 3 14 19
2024/202561 9 11 9 32 0 0 0 0 0 0 0 0
Totale 249